AGEN
#3142
Agenus Inc. - Common Stock
8.1 4 USD
+0.01%
Market Price
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
Range Annuel
Changement quotidien
+1.25%
Changement Mensuel
+3.69%
Evolution sur 6 mois
+153.58%
Changement Annuel
+91.98%
Clôture Précédente
8.0 9
Open
8.1 2
Low
8.1 0
High
8.2 7
Volume
172
Financials
- Market Capitalization 366.47 M
- Employee 81
- Founded 1999
- CEO N/A
- Website www.agenusbio.com
- Headquarter Delaware, United States
- FIGI BBG000C8SWQ9
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
1.01
ratio cours/chiffre d'affaires
0.81
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 3130 |  IRD Opus Genetics, Inc. - Common Stock | 4.45 USD | +16.19% | +14.99% | +21.25% | +19.62% | 370.22 M USD | ||
| 3137 |  LYEL Lyell Immunopharma, Inc. - Common Stock | 14.96 USD | +2.96% | +2.12% | +16.24% | -38.16% | 366.60 M USD | ||
| 3143 |  DMAC DiaMedica Therapeutics Inc. - Common Stock | 6.75 USD | +4.65% | -0.15% | +2.27% | +27.60% | 364.00 M USD | ||
| 3182 |  IKT Inhibikase Therapeutics, Inc. - Common Stock | 2.48 USD | -0.80% | +0.40% | +10.22% | +43.35% | 346.05 M USD |